Oraparm and 'Business Collaboration for Oral Probiotic Research and Product Development' Agreement Signed

Yoon Eun-seop, CEO of OraPharm (left), and Jang Seung-hoon, CEO of CJ Wellcare, are posing for a commemorative photo after the signing ceremony.

Yoon Eun-seop, CEO of OraPharm (left), and Jang Seung-hoon, CEO of CJ Wellcare, are posing for a commemorative photo after the signing ceremony.

View original image

[Asia Economy Reporter Eunmo Koo] Healthcare specialist CJ Wellcare announced on the 23rd that it has signed a 'business cooperation agreement for oral probiotic research and product development' with oral probiotic specialist Orapharm.


Orapharm is the first company to introduce oral probiotics in the domestic probiotic market, which has been focused mainly on intestinal probiotics. Oral probiotics help oral immunity by inhibiting harmful bacteria in the mouth while promoting the growth of beneficial bacteria. Recently, as mask-wearing has become routine, demand for related products has rapidly increased.


CJ Wellcare plans to launch BYO brand oral probiotic products using Orapharm's functional strains within the first half of this year. BYO probiotics have expanded their portfolio from skin functional individually recognized probiotics in 2013 to intestinal probiotics. This year, the company aims to strengthen its position in the probiotic market by collaborating with various specialized companies that have secured functional strains.


The domestic probiotic market has steadily grown from 741.5 billion KRW in 2019 to 828.5 billion KRW in 2020, and 842 billion KRW in 2021. Products, which were previously limited to gut health, are now segmented into functionalities such as skin, diet, oral, nasal immunity, and women's health, evolving into products with highly viable plant-based probiotics and guaranteed high counts of probiotics.



A CJ Wellcare official stated, "We expect synergy from the combination of CJ Wellcare's accumulated strain and fermentation technology capabilities and Orapharm's oral functional strains," adding, "We will continue to introduce products that reflect the rapidly changing probiotic trend market."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing